Diabetic nephropathy in African-American patients (Q35946123)

11 August 2017

1 reference

title

Diabetic nephropathy in African-American patients (English)

1 reference

11 August 2017

1 reference

Errol D Crook

1

1 reference

PubMed ID

15539011

11 August 2017

Sejal R Patel

series ordinal

2

1 reference

11 August 2017

1 December 2004

1 reference

11 August 2017

7

1 reference

inferred from page(s)

published in

Current diabetes report

1 reference

11 August 2017

4

1 reference

11 August 2017

6

1 reference

11 August 2017

455-461

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-004-0056-y

11 August 2017

0 references

cites work

The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-004-0056-Y

Non-insulin-dependent diabetes mellitus in minorities in the United States

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-004-0056-Y

Renal disease in hypertensive adults: effect of race and type II diabetes mellitus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-004-0056-Y

Heterogeneous nature of renal lesions in type II diabetes

21 January 2018

1 reference

12 December 2020

High prevalence of albuminuria among African-Americans with short duration of diabetes

1 reference

12 December 2020

Diabetic renal disease in African Americans

1 reference

12 December 2020

Common variants in glutamine:fructose-6-phosphate amidotransferase 2 (GFPT2) gene are associated with type 2 diabetes, diabetic nephropathy, and increased GFPT2 mRNA levels

1 reference

12 December 2020

Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.

1 reference

12 December 2020

Risk factors for microalbuminuria in black americans with newly diagnosed type 2 diabetes

1 reference

12 December 2020

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

1 reference

12 December 2020

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

1 reference

12 December 2020

Endstage renal disease owing to diabetic nephropathy in Mississippi: an examination of factors influencing renal survival in a population prone to late referral

1 reference

12 December 2020

Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study.

1 reference

12 December 2020

Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial.

1 reference

12 December 2020

The effect of enalapril on advanced diabetic nephropathy in African-American females

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Incidence and risk factors for cardiovascular disease in African Americans with diabetes: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

12 December 2020

Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease

1 reference

12 December 2020

Angiotensin-converting enzyme genotype in blacks with diabetic nephropathy: effects on risk of diabetes and its complications

1 reference

12 December 2020

Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy

1 reference

12 December 2020

Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Are low target blood pressure goals justified in persons with diabetes mellitus?

1 reference

12 December 2020

The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?

1 reference

12 December 2020

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

1 reference

12 December 2020

Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure

1 reference

12 December 2020

Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy

1 reference

12 December 2020

Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: the involvement of protein kinases A and C.

1 reference

12 December 2020

Relative effects of angiotensin converting enzyme inhibitors and calcium antagonists in advanced diabetic nephropathy.

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

12 December 2020

Diabetes in urban African-Americans. II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes

1 reference

12 December 2020

Cross-sectional analysis of renal function in black Americans with NIDDM

1 reference

12 December 2020

Elevated blood pressure among U.S. adults with diabetes, 1988-1994

1 reference

12 December 2020

Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Advanced diabetic nephropathy disproportionately affects African-American females: cross-sectional analysis and determinants of renal survival in an academic renal clinic

1 reference

12 December 2020

Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans

1 reference

12 December 2020

Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

1 reference

12 December 2020

Diabetic nephropathy in African Americans

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

End-stage renal disease in specific ethnic and racial groups: risk factors and benefits of antihypertensive therapy

1 reference

12 December 2020

A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study

1 reference

12 December 2020

Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

10.1007/S11892-004-0056-Y

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15539011